Dominguez, I.
Cruz-Gamero, J. M.
Corasolla, V.
Dacher, N.
Rangasamy, S.
Urbani, A.
Narayanan, V.
Rebholz, H. http://orcid.org/0000-0002-0400-7547
Funding for this research was provided by:
Csnk2a1 foundation
Rare Disease Foundation
National Institute of General Medical Sciences (1R01GM098367)
CTSA (UL1-TR000157)
Article History
Received: 10 January 2021
Accepted: 31 March 2021
First Online: 4 May 2021
Declarations
:
: The authors declare no competing interests.
: The Ethics approvals are mentioned in the Methods section: The fibroblast study protocol and consent were approved by the Western Institutional Review Board research protocol (20120789). Ethics approval for work with the fibroblasts was also granted by the Cellule bioethique DGRI-SPFCO-B5 of the French Ministry of Higher Education, Research and Innovation (DC-2019-3665). Mouse experiments were approved by the Boston University Medical Center Institutional Animal Care and Use Committee (IACUC, PROTO201800107).
: All authors have read and approved the manuscript and consented for publication.